Natriuretic peptides in the central nervous system: Novel targets for cognitive impairment

Simin Mahinrad, Anton J M de Craen, Sevil Yasar, Diana van Heemst, Behnam Sabayan

Research output: Contribution to journalReview article

Abstract

Natriuretic peptides (NPs) are traditionally known as cardiac hormones with diuretic, natriuretic and blood pressure lowering properties. Evidence indicates that NPs and their receptors are abundant in the central nervous system, suggesting their involvement in regulation of various brain functions. It has been shown that NPs are involved in the regulation of neurovascular and blood-brain barrier integrity, neuro-inflammation, neuroprotection, synaptic transmission and brain fluid homeostasis. In addition, NPs might contribute to the brain's inhibitory control over the hypothalamic-pituitary-adrenal axis. Studies have also shown that high systemic levels of NPs are associated with cognitive impairment independent of cardiovascular risk factors. In this review we discuss the potential roles of NPs in regulating structural and functional integrity of the brain. Based on the available neurobiological and clinical evidence, we propose that NPs might represent as potential novel diagnostic and therapeutic targets for cognitive impairment.

Original languageEnglish (US)
Pages (from-to)148-156
Number of pages9
JournalNeuroscience and Biobehavioral Reviews
Volume68
DOIs
StatePublished - Sep 1 2016

Fingerprint

Natriuretic Peptides
Central Nervous System
Brain
Peptide Receptors
Cognitive Dysfunction
Blood-Brain Barrier
Diuretics
Synaptic Transmission
Homeostasis
Hormones
Blood Pressure
Inflammation

Keywords

  • Central nervous system
  • Cognitive impairment
  • Natriuretic peptides

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Cognitive Neuroscience
  • Neuropsychology and Physiological Psychology

Cite this

Natriuretic peptides in the central nervous system : Novel targets for cognitive impairment. / Mahinrad, Simin; de Craen, Anton J M; Yasar, Sevil; van Heemst, Diana; Sabayan, Behnam.

In: Neuroscience and Biobehavioral Reviews, Vol. 68, 01.09.2016, p. 148-156.

Research output: Contribution to journalReview article

Mahinrad, Simin ; de Craen, Anton J M ; Yasar, Sevil ; van Heemst, Diana ; Sabayan, Behnam. / Natriuretic peptides in the central nervous system : Novel targets for cognitive impairment. In: Neuroscience and Biobehavioral Reviews. 2016 ; Vol. 68. pp. 148-156.
@article{19b3fa91793f4cf391174505758a4af7,
title = "Natriuretic peptides in the central nervous system: Novel targets for cognitive impairment",
abstract = "Natriuretic peptides (NPs) are traditionally known as cardiac hormones with diuretic, natriuretic and blood pressure lowering properties. Evidence indicates that NPs and their receptors are abundant in the central nervous system, suggesting their involvement in regulation of various brain functions. It has been shown that NPs are involved in the regulation of neurovascular and blood-brain barrier integrity, neuro-inflammation, neuroprotection, synaptic transmission and brain fluid homeostasis. In addition, NPs might contribute to the brain's inhibitory control over the hypothalamic-pituitary-adrenal axis. Studies have also shown that high systemic levels of NPs are associated with cognitive impairment independent of cardiovascular risk factors. In this review we discuss the potential roles of NPs in regulating structural and functional integrity of the brain. Based on the available neurobiological and clinical evidence, we propose that NPs might represent as potential novel diagnostic and therapeutic targets for cognitive impairment.",
keywords = "Central nervous system, Cognitive impairment, Natriuretic peptides",
author = "Simin Mahinrad and {de Craen}, {Anton J M} and Sevil Yasar and {van Heemst}, Diana and Behnam Sabayan",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.neubiorev.2016.05.022",
language = "English (US)",
volume = "68",
pages = "148--156",
journal = "Neuroscience and Biobehavioral Reviews",
issn = "0149-7634",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Natriuretic peptides in the central nervous system

T2 - Novel targets for cognitive impairment

AU - Mahinrad, Simin

AU - de Craen, Anton J M

AU - Yasar, Sevil

AU - van Heemst, Diana

AU - Sabayan, Behnam

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Natriuretic peptides (NPs) are traditionally known as cardiac hormones with diuretic, natriuretic and blood pressure lowering properties. Evidence indicates that NPs and their receptors are abundant in the central nervous system, suggesting their involvement in regulation of various brain functions. It has been shown that NPs are involved in the regulation of neurovascular and blood-brain barrier integrity, neuro-inflammation, neuroprotection, synaptic transmission and brain fluid homeostasis. In addition, NPs might contribute to the brain's inhibitory control over the hypothalamic-pituitary-adrenal axis. Studies have also shown that high systemic levels of NPs are associated with cognitive impairment independent of cardiovascular risk factors. In this review we discuss the potential roles of NPs in regulating structural and functional integrity of the brain. Based on the available neurobiological and clinical evidence, we propose that NPs might represent as potential novel diagnostic and therapeutic targets for cognitive impairment.

AB - Natriuretic peptides (NPs) are traditionally known as cardiac hormones with diuretic, natriuretic and blood pressure lowering properties. Evidence indicates that NPs and their receptors are abundant in the central nervous system, suggesting their involvement in regulation of various brain functions. It has been shown that NPs are involved in the regulation of neurovascular and blood-brain barrier integrity, neuro-inflammation, neuroprotection, synaptic transmission and brain fluid homeostasis. In addition, NPs might contribute to the brain's inhibitory control over the hypothalamic-pituitary-adrenal axis. Studies have also shown that high systemic levels of NPs are associated with cognitive impairment independent of cardiovascular risk factors. In this review we discuss the potential roles of NPs in regulating structural and functional integrity of the brain. Based on the available neurobiological and clinical evidence, we propose that NPs might represent as potential novel diagnostic and therapeutic targets for cognitive impairment.

KW - Central nervous system

KW - Cognitive impairment

KW - Natriuretic peptides

UR - http://www.scopus.com/inward/record.url?scp=84971618276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971618276&partnerID=8YFLogxK

U2 - 10.1016/j.neubiorev.2016.05.022

DO - 10.1016/j.neubiorev.2016.05.022

M3 - Review article

C2 - 27229760

AN - SCOPUS:84971618276

VL - 68

SP - 148

EP - 156

JO - Neuroscience and Biobehavioral Reviews

JF - Neuroscience and Biobehavioral Reviews

SN - 0149-7634

ER -